GM
Geoff Meacham
#91 out of 1697 analysts
Citigroup
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
104.91%
Gain +4.72%
Monthly
1%
Yearly
12.7%
Drawdown
51.9%
$294,913.41
Equity
Holdings
$294,738.72
Cash
$174.69
Investment
$296,013.94
$194,738.54
Profit +$13,301.21
Realized
$196,013.76
Unrealized
-$1,275.22
Dividends
-$56,041.37
$174.69
Cash
Deposits
$100,174.88
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
4.72%
Profit
$13,301.21
Win %
33%
This Week
Compared To Last Week
Gain
4.43%
Profit
$12,518.89
Win %
50%
This Month
Compared to last month
Gain
4.95%
Profit
$13,907.88
Win %
65%
This Year
Compared to last year
Gain
37.86%
Profit
$80,995.09
Win %
69%
Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 1034 | Longs Won 606/952 63% | Profit Factor 1.92 |
| Profitability | Shorts Won 36/82 43% | Standard Deviation $3,542.47 |
| Average Win $814.34 | Best Trade (Mar 13) $62,432.28 | Sharpe Ratio -108.53 |
| Average Loss -$693.94 | Worst Trade (Nov 29) -$34,030.52 | Z-Score -12.91 (100%) |
| Commissions $0 | Avg. Trade Length 2m 1d | Expectancy $188.34 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | 0.03% | 0.22% | 1.11% | 4.33% | 14.02% | 39.55% |
| Consecutive Losing Trades | 425 | 382 | 340 | 297 | 255 | 212 | 170 | 127 | 85 | 42 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 BBIO BridgeBio Pharma, Inc. | 1,184.49 | $99,141.54 | $94,593.11 | - | -$4,548.43 | -4.59% | -1.662% |
 PTCT PTC Therapeutics, Inc. | 1,345.2 | $99,141.54 | $96,451.13 | - | -$2,690.41 | -2.71% | -0.375% |
 PTGX Protagonist Therapeutics Inc. | 668.57 | $97,730.87 | $103,694.48 | - | $5,963.61 | 6.1% | +2.43% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
